← Back to catalogue

ULTRAMED NASAL OXYGEN CANNULA (TWIN BORE NASAL OXYGEN CANNULA)- Neonatal

EUDAMED

Class IIa (EU MDR)

Ref 2003-03/NModel ULTRAMED NASAL OXYGEN CANNULA (TWIN BORE NASAL OXYGEN CANNULA)- NeonatalModel ULTRAMED NASAL OXYGEN CANNULA (TWIN BORE NASAL OXYGEN CANNULA)

by Ultra For Medical Products (Ultramed) U.M.I.C (S.A.E)

Identity

Trade Name
ULTRAMED NASAL OXYGEN CANNULA (TWIN BORE NASAL OXYGEN CANNULA)- Neonatal EUDAMED
Device Name
ULTRAMED NASAL OXYGEN CANNULA (TWIN BORE NASAL OXYGEN CANNULA) EUDAMED
Model / Reference
ULTRAMED NASAL OXYGEN CANNULA (TWIN BORE NASAL OXYGEN CANNULA)- Neonatal EUDAMED
2003-03/N EUDAMED
ULTRAMED NASAL OXYGEN CANNULA (TWIN BORE NASAL OXYGEN CANNULA) EUDAMED

Identifiers

Primary DI / UDI-DI
06223004254796 EUDAMED
Basic UDI-DI
B-06223004254796 EUDAMED
622300425NOC2003T8 EUDAMED
EMDN Code
R0301020301 OXYGEN THERAPY STANDARD NASAL CANNULAS (GOGGLES) EUDAMED

Classification

Device Class
Class IIa EUDAMED
Market of Registration
Romania EUDAMED

Clinical & Handling

Sterile

No

EUDAMED

Implantable

No

EUDAMED

Reusable

No

EUDAMED

Contains Latex

No

EUDAMED

Reprocessed

No

EUDAMED

CMR Substance

No

EUDAMED

Human-derived

No

EUDAMED

Human Tissues

No

EUDAMED

Animal Tissues

No

EUDAMED

Endocrine Disruptor

No

EUDAMED

Administering Medicine

No

EUDAMED

Measuring Function

No

EUDAMED

Incorporates Medicinal Product

No

EUDAMED

ULTRAMED NASAL OXYGEN CANNULA (TWIN BORE NASAL OXYGEN CANNULA)- Neonatal by Ultra For Medical Products (Ultramed) U.M.I.C (S.A.E) — Class IIa — MDR, MDD…

Authorization Coverage (European Union — 27 member states)

Regulatory Authorizations

European Union Active

CE/MDR

European Union Active

CE/MDD

Is this your device? Claim it to add documentation and request validation.

Manufacturer

EUDAMED SRN
EG-MF-000038562
Authorised Representative
Obelis s.a. BE-AR-000000106

Sources (2)

  • EUDAMED f7261d41-83c7-458c-a4fc-38a69a759474 61 fields · synced Oct 6, 2026
  • EUDAMED 4dbdc9e1-f855-4045-b7e5-f5e71dd98bbf 61 fields · synced May 19, 2026